Record Information |
---|
Version | 2.0 |
---|
Created at | 2005-11-16 15:48:42 UTC |
---|
Updated at | 2020-11-24 22:19:00 UTC |
---|
NP-MRD ID | NP0000870 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Aspartylphenylalanine |
---|
Description | This is a metabolic byproduct of aspartame (Nutrasweet). Aspartame is the methyl ester of aspartylphenylalanine. After hydrolysis of the ester bond in the intestinal lumen, the dipeptide is apparently absorbed and digested in the same manner as dipeptides derived from protein digestion. There are several Asp-Phe dipeptidases that degrade this peptide. It has been suggested that individuals with aspartame allergies may be defficient in this peptidase. (PMID 3743970 ). It has been observed that the N-beta-L-aspartyl-L-phenylalanine (a breakdown product of Asn-Phe) is a naturally occurring peptide found in both blood and urine.(PMID: 2723819 ). |
---|
Structure | N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O InChI=1S/C13H16N2O5/c14-9(7-11(16)17)12(18)15-10(13(19)20)6-8-4-2-1-3-5-8/h1-5,9-10H,6-7,14H2,(H,15,18)(H,16,17)(H,19,20)/t9-,10-/m0/s1 |
---|
Synonyms | Value | Source |
---|
alpha-Aspartylphenylalanine | ChEBI | Aspartyl-phenylalanine | ChEBI | Demethylaspartame | ChEBI | DF | ChEBI | L-alpha-Asp-L-phe | ChEBI | L-Asp-L-phe | ChEBI | L-Aspartyl-L-phenylalanine | ChEBI | a-Aspartylphenylalanine | Generator | Α-aspartylphenylalanine | Generator | L-a-Asp-L-phe | Generator | L-Α-asp-L-phe | Generator | 3-Amino-N-(a-carboxyphenethyl)-succinamic acid stereoisomer | HMDB | 3-Amino-N-(carboxyphenethyl)-succinamic acid stereoisomer | HMDB | a-L-Aspartyl-L-phenylalanine | HMDB | alpha-L-Aspartyl-L-phenylalanine | HMDB | L-a-Aspartyl-L-phenylalanine | HMDB | L-alpha-Aspartyl-L-phenylalanine | HMDB | N-L-a-Aspartyl-L-phenylalanine | HMDB | N-L-alpha-Aspartyl-L-phenylalanine | HMDB | N-L-Aspartyl-L-phenylalanine | HMDB | Asp-phe | HMDB | Aspartate phenylalanine dipeptide | HMDB | Aspartate-phenylalanine dipeptide | HMDB | Aspartic acid phenylalanine dipeptide | HMDB | Aspartic acid-phenylalanine dipeptide | HMDB | D-F Dipeptide | HMDB | DF Dipeptide | HMDB | L-Α-aspartyl-L-phenylalanine | HMDB | N-Aspartylphenylalanine | HMDB | N-L-alpha-Aspartylphenylalanine | HMDB | N-L-Α-aspartyl-L-phenylalanine | HMDB | N-L-Α-aspartylphenylalanine | HMDB | N-alpha-Aspartylphenylalanine | HMDB | N-alpha-L-Aspartyl-L-phenylalanine | HMDB | N-Α-aspartylphenylalanine | HMDB | N-Α-L-aspartyl-L-phenylalanine | HMDB | alpha-Asp-phe | HMDB | alpha-L-Asp-L-phe | HMDB | Α-asp-phe | HMDB | Α-L-asp-L-phe | HMDB | Α-L-aspartyl-L-phenylalanine | HMDB | Aspartylphenylalanine | ChEBI |
|
---|
Chemical Formula | C13H16N2O5 |
---|
Average Mass | 280.2765 Da |
---|
Monoisotopic Mass | 280.10592 Da |
---|
IUPAC Name | (3S)-3-amino-3-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}propanoic acid |
---|
Traditional Name | L-aspartyl-L-phenylalanine |
---|
CAS Registry Number | 13433-09-5 |
---|
SMILES | N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O |
---|
InChI Identifier | InChI=1S/C13H16N2O5/c14-9(7-11(16)17)12(18)15-10(13(19)20)6-8-4-2-1-3-5-8/h1-5,9-10H,6-7,14H2,(H,15,18)(H,16,17)(H,19,20)/t9-,10-/m0/s1 |
---|
InChI Key | YZQCXOFQZKCETR-UWVGGRQHSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Not Available |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as peptides. Peptides are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Peptides |
---|
Alternative Parents | |
---|
Substituents | - Alpha peptide
- Phenylalanine or derivatives
- N-acyl-alpha-amino acid
- N-acyl-alpha amino acid or derivatives
- Beta amino acid or derivatives
- 3-phenylpropanoic-acid
- Alpha-amino acid or derivatives
- Amphetamine or derivatives
- Monocyclic benzene moiety
- Dicarboxylic acid or derivatives
- Benzenoid
- Amino acid or derivatives
- Amino acid
- Carboximidic acid derivative
- Carboxylic acid
- Carboximidic acid
- Propargyl-type 1,3-dipolar organic compound
- Organic 1,3-dipolar compound
- Organic nitrogen compound
- Primary aliphatic amine
- Organonitrogen compound
- Organooxygen compound
- Primary amine
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Amine
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | 236 - 239 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Burton EG, Schoenhard GL, Hill JA, Schmidt RE, Hribar JD, Kotsonis FN, Oppermann JA: Identification of N-beta-L-aspartyl-L-phenylalanine as a normal constituent of human plasma and urine. J Nutr. 1989 May;119(5):713-21. [PubMed:2723819 ]
- Tobey NA, Heizer WD: Intestinal hydrolysis of aspartylphenylalanine--the metabolic product of aspartame. Gastroenterology. 1986 Oct;91(4):931-7. [PubMed:3743970 ]
- Mizuma T, Masubuchi S, Awazu S: Intestinal absorption of stable cyclic dipeptides by the oligopeptide transporter in rat. J Pharm Pharmacol. 1998 Feb;50(2):167-72. [PubMed:9530984 ]
- Burgert SL, Andersen DW, Stegink LD, Takeuchi H, Schedl HP: Metabolism of aspartame and its L-phenylalanine methyl ester decomposition product by the porcine gut. Metabolism. 1991 Jun;40(6):612-8. [PubMed:1865825 ]
- Benoiton NL, Chen FM: 2,4-Dimethyl-5(4H)-oxazolone as reagent for activation and coupling of N-substituted aspartic acid. Int J Pept Protein Res. 1994 Aug;44(2):139-42. [PubMed:7982757 ]
- Goodman M, Mattern RH, Gantzel P, Santini A, Iacovino R, Saviano M, Benedetti E: X-ray structures of new dipeptide taste ligands. J Pept Sci. 1998 Jun;4(4):229-38. [PubMed:9680057 ]
- Pattanaargson S, Sanchavanakit C: Aspartame degradation study using electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom. 2000;14(11):987-93. [PubMed:10844736 ]
- Schwerdt G, Freudinger R, Silbernagl S, Gekle M: Apical uptake of radiolabelled ochratoxin A into Madin-Darby canine kidney cells. Toxicology. 1998 Nov 16;131(2-3):193-202. [PubMed:9928634 ]
- Leung SS, Grant DJ: Solid state stability studies of model dipeptides: aspartame and aspartylphenylalanine. J Pharm Sci. 1997 Jan;86(1):64-71. [PubMed:9002461 ]
|
---|